Opko Health Inc (OPK) concluded trading on Thursday at a closing price of $1.45, with 5.78 million shares of worth about $8.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 15.08% during that period and on November 07, 2024 the price saw a loss of about -1.36%. Currently the company’s common shares owned by public are about 773.28M shares, out of which, 325.95M shares are available for trading.
Stock saw a price change of -3.97% in past 5 days and over the past one month there was a price change of -3.33%. Year-to-date (YTD), OPK shares are showing a performance of -3.97% which increased to 8.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.85 but also hit the highest price of $1.75 during that period. The average intraday trading volume for Opko Health Inc shares is 3.21 million. The stock is currently trading -1.73% below its 20-day simple moving average (SMA20), while that difference is down -4.43% for SMA50 and it goes to 10.55% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Opko Health Inc (NASDAQ: OPK) currently have 773.28M outstanding shares and institutions hold larger chunk of about 29.29% of that.
The stock has a current market capitalization of $1.01B and its 3Y-monthly beta is at 1.62. It has posted earnings per share of -$0.33 in the same period. It has Quick Ratio of 1.36 while making debt-to-equity ratio of 0.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OPK, volatility over the week remained 5.40% while standing at 4.59% over the month.
Stock’s fiscal year EPS is expected to drop by -20.67% while it is estimated to increase by 4.97% in next year. EPS is likely to grow at an annualized rate of 12.00% for next 5-years, compared to annual growth of 1.56% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barrington Research on June 29, 2023 offering an Outperform rating for the stock and assigned a target price of $2 to it. Coverage by H.C. Wainwright stated Opko Health Inc (OPK) stock as a Buy in their note to investors on December 15, 2022, suggesting a price target of $3 for the stock. On January 24, 2022, Barrington Research Downgrade their recommendations, while on June 21, 2021, Ladenburg Thalmann Initiated their ratings for the stock with a price target of $7. Stock get an Overweight rating from Piper Jaffray on November 25, 2019.
